OpenCitations
metadata only
Phase I Study Of Single-Agent CC-292, A Highly Selective Brutons Tyrosine Kinase Inhibitor, In Relapsed/Refractory Chronic Lymphocytic Leukemia
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- DYNAmic Immune Microenvironment of HCC Treated With atezolIzumab Plus bevaCizumab#900625
- Western-style diet-induced microbial shifts and inflammation reprogram c-Kit⁺ secretory cells into targets for tumor initiation#459874
- Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer#813593
- Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure#463710
- Efficacy and Safety of Linperlisib in Relapsed/Refractory Large Granular T Lymphocytic Leukemia#916615
Record · ID 19621
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive